As of April 2024 Genetic Technologies has a market cap of $9.87 Million. This makes Genetic Technologies the world's 8135th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $9.87 M | -9.69% |
2023 | $10.93 M | -39.58% |
2022 | $18.1 M | -45.86% |
2021 | $33.44 M | -29.81% |
2020 | $47.64 M | 204.51% |
2019 | $15.64 M | 40% |
2018 | $11.17 M | -54.71% |
2017 | $24.67 M | 80.78% |
2016 | $13.64 M | -56.29% |
2015 | $31.22 M | 199.81% |
2014 | $10.41 M | -63.48% |
2013 | $28.51 M | -16.81% |
2012 | $34.28 M | -33.83% |
2011 | $51.81 M | 282.09% |
2010 | $13.56 M | -4.06% |
2009 | $14.13 M | 4.01% |
2008 | $13.58 M | -73.82% |
2007 | $51.89 M | -49.62% |
2006 | $0.10 B | -12.43% |
2005 | $0.11 B | 155.12% |
2004 | $46.11 M | 13.18% |
2003 | $40.73 M |
On Apr 25th, 2024 the market cap of Genetic Technologies was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $218.23 B | 2,209,174.67% | ๐บ๐ธ USA |
Quest Diagnostics
DGX | $15.04 B | 152,195.22% | ๐บ๐ธ USA |
Danaher DHR | $182.06 B | 1,842,950.68% | ๐บ๐ธ USA |
LabCorp LH | $16.72 B | 169,170.19% | ๐บ๐ธ USA |
Compugen CGEN | $0.18 B | 1,730.31% | ๐ฎ๐ฑ Israel |
Neogen NEOG | $2.59 B | 26,125.66% | ๐บ๐ธ USA |
Myriad Genetics MYGN | $1.62 B | 16,368.53% | ๐บ๐ธ USA |
Eterna Therapeutics ERNA | $9.39 M | -4.94% | ๐บ๐ธ USA |